Eleanor Clancy‐Thompson

637 total citations
11 papers, 235 citations indexed

About

Eleanor Clancy‐Thompson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Eleanor Clancy‐Thompson has authored 11 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Eleanor Clancy‐Thompson's work include Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (7 papers) and T-cell and B-cell Immunology (4 papers). Eleanor Clancy‐Thompson is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (7 papers) and T-cell and B-cell Immunology (4 papers). Eleanor Clancy‐Thompson collaborates with scholars based in United States, Switzerland and China. Eleanor Clancy‐Thompson's co-authors include David W. Mullins, Craig L. Slingluff, Stephanie K. Dougan, Marie D. Burdick, Lynn T. Dengel, Robert M. Strieter, Lestat R. Ali, Patrick T. Bruck, Paul Tyler and Marta Barisa and has published in prestigious journals such as The EMBO Journal, The Journal of Immunology and Scientific Reports.

In The Last Decade

Eleanor Clancy‐Thompson

11 papers receiving 233 citations

Peers

Countries citing papers authored by Eleanor Clancy‐Thompson

Since Specialization

Citations

This map shows the geographic impact of Eleanor Clancy‐Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor Clancy‐Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor Clancy‐Thompson more than expected).

Fields of papers citing papers by Eleanor Clancy‐Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleanor Clancy‐Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor Clancy‐Thompson. The network helps show where Eleanor Clancy‐Thompson may publish in the future.

Co-authorship network of co-authors of Eleanor Clancy‐Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor Clancy‐Thompson. A scholar is included among the top collaborators of Eleanor Clancy‐Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor Clancy‐Thompson. Eleanor Clancy‐Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	cIAP1/2 Antagonism Induces Antigen-Specific T Cell–Dependent Immunity 2023 ·The Journal of Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Stephanie J. Crowley, Patrick T. Bruck, Max Heckler, Patrick J. Lenehan, Lestat R. Ali, (unknown), (unknown), Eleanor Clancy‐Thompson, Winiffer D. Conce Alberto, Megan T. Hoffman, Qiang Li, Marc R. Pelletier, (unknown), Michael Dougan, Stephanie K. Dougan	7
2	469 Preclinical studies support clinical development of AZD2936, a monovalent bispecific humanized antibody targeting PD-1 and TIGIT 2022 ·Regular and Young Investigator Award Abstracts ·(unknown), Deepali Malhotra, (unknown), Eleanor Clancy‐Thompson, Bilal Omar, Brian Naiman, Michael G. Overstreet, Devon K. Taylor, (unknown), Kathy Mulgrew, (unknown), Yue Wang, Gordon Moody, Mark Cobbold, Yariv Mazor, Scott A. Hammond, Kristen Pollizzi	5
3	461 Generation of AZD7789, a novel PD-1 and TIM-3 targeting bispecific antibody, which binds to a differentiated epitope of TIM-3 2022 ·Regular and Young Investigator Award Abstracts ·Eleanor Clancy‐Thompson, (unknown), (unknown), Ashvin R. Jaiswal, Vaheh Oganesyan, (unknown), (unknown), Andrew Garcia, Wen‐Han Yu, James A. Moynihan, Caroline Miller, Kathy Mulgrew, Mark Cobbold, Yariv Mazor, Scott A. Hammond, Kristen Pollizzi	7
4	Transnuclear mice reveal Peyer's patch iNKT cells that regulate B‐cell class switching to IgG1 2019 ·The EMBO Journal ·Eleanor Clancy‐Thompson, (unknown), Nelson M. LaMarche, Lestat R. Ali, Hee‐Jin Jeong, Stephanie J. Crowley, Kelly Boelaars, Michael B. Brenner, Lydia Lynch, Stephanie K. Dougan	7
5	Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell–Effector Responses 2018 ·Cancer Immunology Research ·Eleanor Clancy‐Thompson, (unknown), Paul Tyler, (unknown), Lestat R. Ali, (unknown), (unknown), Patrick T. Bruck, Michael E. Birnbaum, Stephanie K. Dougan	15
6	IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells 2017 ·Cancer Immunology Research ·Eleanor Clancy‐Thompson, Lestat R. Ali, Patrick T. Bruck, Mark A. Exley, Richard S. Blumberg, Glenn Dranoff, Michael Dougan, Stephanie K. Dougan	24
7	CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases 2017 ·Scientific Reports ·(unknown), Eleanor Clancy‐Thompson, David W. Mullins	26
8	Monoclonal Invariant NKT (iNKT) Cell Mice Reveal a Role for Both Tissue of Origin and the TCR in Development of iNKT Functional Subsets 2017 ·The Journal of Immunology ·Eleanor Clancy‐Thompson, (unknown), Paul Tyler, (unknown), Marta Barisa, Patrick J. Brennan, Hidde L. Ploegh, Stephanie K. Dougan	28
9	Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease 2015 ·Cancer Immunology Research ·Eleanor Clancy‐Thompson, (unknown), Walburga Croteau, Matthew P. Alexander, (unknown), Mary Jo Turk, Yina H. Huang, David W. Mullins	34
10	Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen–Specific CD8 T Cells 2013 ·Cancer Immunology Research ·Eleanor Clancy‐Thompson, (unknown), (unknown), Irene M. Mullins, Craig L. Slingluff, David W. Mullins	24
11	Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma 2010 ·Journal of Immunotherapy ·Lynn T. Dengel, (unknown), (unknown), Eleanor Clancy‐Thompson, Marie D. Burdick, Robert M. Strieter, Craig L. Slingluff, David W. Mullins	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact